arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Penumbra, Inc.

PEN Health Care Medical/Dental Instruments
$324.96
▲ +0.2% Today
as of Oct 22, 16:51 ET
Last 30 days +1.59% Sep 14 → Oct 22
$315.66 $318.16 $320.65 $323.15 $325.65 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$323.50
High
$325.45
Low
$323.67
Volume
$469,941
Avg Vol
$568,907
Mkt Cap
$12.5B
P/E (TTM)
111.80
Beta
—
52w High
$362.41
52w Low
$221.26
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 7 items

Oct 20 · 13:00 PR PR Newswire
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
Oct 8 · 16:20 Simply Wall St.
Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus
Oct 1 · 14:40 Zacks
IART vs. PEN: Which Stock Is the Better Value Option?
▸ Show all 7 press releases & news Free account →

PEN earnings at a glance

Penumbra, Inc. (PEN) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. The options market is pricing a move of about ±0.5% after the report, a range of roughly $323.47 to $326.45 from today's $324.96. Over its last 6 reports the stock rose the next day 5 times and fell 1, moving ±6.2% on average; after the most recent report on Jul 30, 2026 it moved +0.4%. That means options currently expect less movement than PEN has typically delivered. PEN beat the consensus EPS estimate in 4 of its last 6 reported quarters. Implied volatility is currently 4%. The share price of $324.96 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$221
$362
73% of range
Avg surprise (last 6)
-0.8%
Avg reaction (last 6)
+6.1%
83% positive
Latest IV / EM
4%
EM ±0.5% · $320 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.55$-0.87$-0.19$0.50$1.18 Actual $0.22Actual $0.48Actual $0.23Actual $0.28Actual $-1.55Actual $0.75Actual $0.83Est $0.66Actual $0.86Est $0.81Actual $0.97Est $0.90Actual $1.18Est $1.12Actual $0.82Est $1.11Actual $0.88Est $1.15 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/20268K
Revenue vs Net Income Revenue Net income
$0$102M$205M$307M$410M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 30, 20268K 2026-07-30 $0.88 $1.15 -23.5% — +0.4% earnings
Wed May 6, 2026Mar/2026 $0.82 $1.11 -26.1% -1.2% +0.1% earnings
Wed Feb 25, 20268K 2026-02-25 $1.18 $1.12 +5.4% — -0.3% earnings
Wed Nov 5, 2025Sep/2025 $0.97 $0.90 +7.8% — +17.3% earnings
Tue Jul 29, 2025Jun/2025 $0.86 $0.81 +6.2% — +11.9% earnings
Wed Apr 23, 2025Mar/2025 $0.83 $0.66 +25.8% — +7.0% earnings
Mon Sep 30, 2024Sep 2024 $0.75 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.55 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.28 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.23 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.48 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.22 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER —$0.97

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$390M$375M—$355M$339M$324M—$301M
Cost of revenue$125M$121M—$114M$115M$108M—$101M
Gross profit$265M$253M—$240M$224M$216M—$200M
Operating income$41M$38M—$49M$41M$40M—$35M
Net income$35M$33M—$46M$45M$39M—$30M
EPS (diluted)$0.88$0.82—$1.17$1.15$1.00—$0.75

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$205M$241M$187M$321M$422M$376M$324M$280M
Inventory$443M$439M$432M$432M$428M$416M$407M$393M
Total current assets$1.34B$1.28B$1.22B$1.14B$1.07B$1000M$951M$892M
Total assets$1.97B$1.90B$1.83B$1.74B$1.67B$1.59B$1.53B$1.48B
Long-term debt————————
Total liabilities$444M$425M$399M$386M$381M$380M$382M$375M
Total equity$1.53B$1.47B$1.43B$1.36B$1.29B$1.21B$1.15B$1.10B

Implied volatility — last 90 days

3%25%47%68%90% Jun 19 — IV 43% · EM ±9.5%Jun 22 — IV 45% · EM ±9.5%Jun 23 — IV 43% · EM ±8.8%Jun 24 — IV 47% · EM ±9.5%Jun 25 — IV 41% · EM ±8.1%Jun 26 — IV 50% · EM ±9.5%Jun 29 — IV 54% · EM ±9.5%Jun 30 — IV 33% · EM ±5.7%Jul 01 — IV 55% · EM ±9.2%Jul 02 — IV 46% · EM ±7.5%Jul 03 — IV 48% · EM ±7.5%Jul 06 — IV 59% · EM ±8.2%Jul 09 — IV 83% · EM ±9.8%Jul 20 — IV 24% · EM ±5.7%Jul 21 — IV 24% · EM ±5.7%Jul 22 — IV 25% · EM ±5.7%Jul 23 — IV 25% · EM ±5.7%Jul 24 — IV 17% · EM ±3.8%Jul 27 — IV 18% · EM ±3.8%Jul 30 — IV 56% · EM ±10.9%Jul 31 — IV 18% · EM ±3.5%Aug 03 — IV 20% · EM ±3.5%Aug 04 — IV 21% · EM ±3.6%Aug 05 — IV 21% · EM ±3.6%Aug 12 — IV 5% · EM ±0.7%Sep 21 — IV 90% · EM ±18.8%Sep 22 — IV 37% · EM ±7.5%Sep 23 — IV 38% · EM ±7.5%Sep 24 — IV 38% · EM ±7.5%Sep 25 — IV 25% · EM ±4.7%Sep 28 — IV 42% · EM ±7.5%Sep 29 — IV 26% · EM ±4.5%Oct 01 — IV 43% · EM ±6.9%Oct 08 — IV 4% · EM ±0.5%

Sector peers

BAX
Baxter International Inc.
$12.4B $25.65+4.7%
SOLV
Solventum Corporation
$14.6B $87.45+1.2%
GKOS
Glaukos Corporation
$10.2B $176.69+1.9%
GMED
Globus Medical, Inc.
$9.9B $81.66+3.4%
PODD
Insulet Corporation
$9.3B $148.12+3.8%
MMED
MiniMed Group, Inc.
$5.7B $18.29+4.6%

PEN earnings FAQ

When is PEN's next earnings date?

Penumbra, Inc. is expected to report on November 4, 2026.

What is PEN's expected move for earnings?

Options currently price a move of about ±0.5%, or $1.49 per share either way from $324.96.

How does PEN stock usually react to earnings?

Across the last 6 reports the average next-day move was ±6.2%, up 5 times and down 1 times.

What is PEN's implied volatility?

PEN's at-the-money implied volatility is about 4% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in